# FDA Inspection 1164669 - Charles Redfern, MD - March 11, 2022

Source: https://www.keypedia.com/records/fda_inspections/charles-redfern-md/26055cd1-48f3-43ae-a26c-09fa5e6af339
Source feed: FDA_Inspections

> FDA Inspection 1164669 for Charles Redfern, MD on March 11, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1164669
- Company Name: Charles Redfern, MD
- Inspection Date: 2022-03-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 640564 - 2010-01-15](https://www.keypedia.com/records/fda_inspections/charles-redfern-md/65612e8f-dea4-469e-85bf-745d8336af77)

Company: https://www.keypedia.com/companies/charles-redfern-md/aaa97826-87aa-478e-be44-4a19e428c3d9

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c